comparemela.com

Latest Breaking News On - Tempest therapeutic - Page 1 : comparemela.com

Tempest Therapeutics : Corporate Presentation - June 2024

Tempest Therapeutics : Corporate Presentation - June 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Exchange-commission-on
Tempest-therapeutics-inc
Securities-act
Tempest-therapeutics
Tempest-therapeutic
Exchange-commission

Tempest Reports First Quarter 2024 Financial Results and Provides Business Update

Tempest Reports First Quarter 2024 Financial Results and Provides Business Update
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Brisbane
Queensland
Australia
California
United-states
American
Stephen-brady
Aljanae-reynolds
Sylvia-wheeler
Exchange-commission
Society-for-immunotherapy-of-cancer
American-association-for-cancer-research

Tempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual Meeting

BRISBANE, Calif., April 09, 2024 Tempest Therapeutics, Inc. , a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, today.

United-states
California
Brisbane
Queensland
Australia
American
Sylvia-wheeler
Sam-whiting
Aljanae-reynolds
Exchange-commission-on
American-association-for-cancer-research
Exchange-commission

Tempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research Communications

TPST-1120, a first-in-class, oral, selective PPAR⍺ antagonist, demonstrates clinical activity in PD-1 inhibitor refractory and immune compromised cancersBased on subsequent positive randomized data,.

California
United-states
Brisbane
Queensland
Australia
Sylvia-wheeler
Aljanae-reynolds
Sam-whiting
Cancer-research-communications
Nasdaq
Exchange-commission-on
Securities-exchange

Tempest Therapeutics : Corporate Presentation - April 2024 -March 29, 2024 at 06:46 pm EDT

Company Overview April 2024 Forward-Looking Statements This presentation contains forward-looking statements.

Dipak-panigrahy
Company-overview
Data-support-clinical-development-strategy
Exchange-commission
Tempest-therapeutics-inc
Securities-act
Tempest-therapeutics
Tempest-therapeutic
First-in-class-oncology-pipeline
Dependent-tumors-inform-clinical
Catenin-pathway-induces
Support-clinical-development

vimarsana © 2020. All Rights Reserved.